glp 1 drugs in development GLP-1R Agonists for Weight Loss A schematic overview of GLP-1

Athauda D, Maclagan K, Skene SS, et al

Tirzepatide was undetectable (below 4 micrograms per liter) in 164 of 171 samples

Timing strategies can help manage these interactions

(2008) 26:871895, vii

Nearly 50% of patients in one study reported having at least one uncomfortable symptom

*Correspondence: Xian-Feng Zhang, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers